| Literature DB >> 26022167 |
Francis J DiMario1, Mustafa Sahin2, Darius Ebrahimi-Fakhari3.
Abstract
Tuberous sclerosis complex is an autosomal-dominant, neurocutaneous, multisystem disorder characterized by cellular hyperplasia and tissue dysplasia. The genetic cause is mutations in the TSC1 gene, found on chromosome 9q34, and TSC2 gene, found on chromosome 16p13. The clinical phenotypes resulting from mutations in either of the 2 genes are variable in each individual. Herein, advances in the understanding of molecular mechanisms in tuberous sclerosis complex are reviewed, and current guidelines for diagnosis, treatment, follow-up, and management are summarized. Published by Elsevier Inc.Entities:
Keywords: Autism; Epilepsy; Mechanistic target of rapamycin (mTOR); Neurocutaneous; Neurogenetic; Rapamycin; Subependymal giant cell astrocytoma; Tuberous sclerosis complex
Mesh:
Substances:
Year: 2015 PMID: 26022167 DOI: 10.1016/j.pcl.2015.03.005
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278